#oncology

FDA Hematology approvals in 2018

FDA highlights approvals in 2018 at recent ASH meeting in San Diego. 2018 saw 32 FDA approvals in hematology including 12 NMEs & 5...

Can you guess who the top 10 cancer drug makers of 2024 will be...see FiercePharma special report.

Top 10 oncology companies by 2024 per FiercePharma

Value: Oncologists disagree on use of value to guide cancer treatments Author

A new study recently published in Value in Health by Risha Gidwani-Marszowski, DrPH, a health economist at the VA Palo Alto Health Care...

Top Selling Drugs of 2018? 5 of 10 predicted be Oncology Products

EvaluatePharma projects the best sellers of 2018. #2018 #drugs #pharmaceuticals #oncology

Women often encountered the "broken rung" along their career journey. What is your experie

Women often encountered the "broken rung" along their career journey. What is your experience?

More I-O targets mean more shots on goal.

New Report Available from ACS: Progress in Global Cancer Fight is not only Possible, but Achievable

Breast Cancer Awareness Month begins today and I honor you!

Great progress in cancer drug development and approvals but still incredible unmet need.

How long should an office visit be? Is 20 minutes enough? Can you call that patient-centric care?

Cancer Medicines Value in Context: PhRMA Report May 2019 - A slide resource kit

Top 20 Drugs of 2018 from Fierce Pharma

IQVIA report outlines key 2018 approvals and more